search
Back to results

General or Regional Anesthesia for Hip Surgery

Primary Purpose

Osteoarthritis

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
GA-arm, remifentanil
RA-arm
Sponsored by
Region Skane
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis focused on measuring anaesthetic techniques, subarachnoid, analgesia

Eligibility Criteria

46 Years - 84 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: patients with osteoarthritis scheduled for surgery

  • patients that will require THA
  • patients over 45 yrs and under 85 yrs.
  • patients that understand the given information and are willing to participate in this study
  • patients who have signed the informed consent document.
  • patients belonging to ASA class I-III.

Exclusion Criteria:

  • prior surgery to the same hip
  • patients with a history of stroke, neurological or psychiatric disease that potentially could affect the perception of pain
  • obesity (BMI > 35)
  • active or suspected infection
  • patients taking opioids or steroids
  • patients suffering from rheumatoid arthritis or an immunological depression
  • patients who are allergic to any of the drugs being used in this study

Sites / Locations

  • Dept Orthopedic Surgey, Hässleholm Hospital, PO Box 351,

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

RA-arm

GA-arm, remifentanil

Arm Description

RA-arm: the patients in this arm will receive intrathecal anaesthesia consisting of bupivacaine 15 mg

GA-arm: patients in this arm will receive general anaesthesia consisting of Target Controlled Infusion (TCI) of remifentanil and propofol

Outcomes

Primary Outcome Measures

Length of Hospital Stay
Time from the end of surgery until the patients meets the discharge criteria will be evaluated. Discharge criteria: able to get in and out of bed, Able to get dressed. Able to sit down in a chair and get up again. Able to walk 50 meters wit/without crutches. Able to flex knee 70 degrees. Able to walk stairs. Pain manageable with oral analgesics. Acceptance to be discharged

Secondary Outcome Measures

Post Operative Pain
Pain will be monitored using a Visual Analogue Scale. Pain will be monitored with the patient in four different positions. VAS 100 mm used for assessment of pain (0 = no pain, 100 = worst imaginable pain). At each time and position the median VAS-pain score was reported (generally the distribution of pain scores are not normally distributed and hence median value was used)

Full Information

First Posted
November 20, 2012
Last Updated
June 10, 2019
Sponsor
Region Skane
search

1. Study Identification

Unique Protocol Identification Number
NCT01733472
Brief Title
General or Regional Anesthesia for Hip Surgery
Official Title
General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
June 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Region Skane

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether general anaesthesia or regional anaesthesia is best for patients undergoing Total Hip Arthroplasty.
Detailed Description
A randomized controlled trial (RCT) with a follow up time of 48 hrs. Patients scheduled for primary Total Hip Arthroplasty. A total of 120 patients randomly assigned to one of the two alternatives (general anaesthesia (GA) or regional anaesthesia (RA)). General anaesthesia compared to intrathecal anaesthesia will give shorter length of hospital stay (LOS) for patients undergoing total hip arthroplasty (THA). Primary endpoint: LOS. Secondary endpoints: Postoperative pain? Postoperative orthostatic function (dizziness) Time until the patient meets the discharge criteria from PACU How many patients will need at least one urinary bladder catheterisation

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
Keywords
anaesthetic techniques, subarachnoid, analgesia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)

8. Arms, Groups, and Interventions

Arm Title
RA-arm
Arm Type
Placebo Comparator
Arm Description
RA-arm: the patients in this arm will receive intrathecal anaesthesia consisting of bupivacaine 15 mg
Arm Title
GA-arm, remifentanil
Arm Type
Experimental
Arm Description
GA-arm: patients in this arm will receive general anaesthesia consisting of Target Controlled Infusion (TCI) of remifentanil and propofol
Intervention Type
Drug
Intervention Name(s)
GA-arm, remifentanil
Other Intervention Name(s)
GA: TCI consisting of remifentanil an propofol
Intervention Description
Remifentanil and propofol will be delivered intravenously via TCI pumps according to the "Marsh" and "Minto" algorithm
Intervention Type
Drug
Intervention Name(s)
RA-arm
Other Intervention Name(s)
Regional anesthesia
Intervention Description
Intrathecal (i.e. spinal) anesthesia with isobaric bupivacaine 15 mg administered intrathecally at L4-L5.
Primary Outcome Measure Information:
Title
Length of Hospital Stay
Description
Time from the end of surgery until the patients meets the discharge criteria will be evaluated. Discharge criteria: able to get in and out of bed, Able to get dressed. Able to sit down in a chair and get up again. Able to walk 50 meters wit/without crutches. Able to flex knee 70 degrees. Able to walk stairs. Pain manageable with oral analgesics. Acceptance to be discharged
Time Frame
Up to 4 days after surgery
Secondary Outcome Measure Information:
Title
Post Operative Pain
Description
Pain will be monitored using a Visual Analogue Scale. Pain will be monitored with the patient in four different positions. VAS 100 mm used for assessment of pain (0 = no pain, 100 = worst imaginable pain). At each time and position the median VAS-pain score was reported (generally the distribution of pain scores are not normally distributed and hence median value was used)
Time Frame
from end of surgey until 48 hrs later
Other Pre-specified Outcome Measures:
Title
Time Hrs Until the Patient Meets the Discharge Criteria From PACU
Description
Hours until the patient meets the discharge criteria from PACU will be monitored every 15 min from teh time the patient arrives to PACU until he/she meets the discharge criteria
Time Frame
12 hrs

10. Eligibility

Sex
All
Minimum Age & Unit of Time
46 Years
Maximum Age & Unit of Time
84 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients with osteoarthritis scheduled for surgery patients that will require THA patients over 45 yrs and under 85 yrs. patients that understand the given information and are willing to participate in this study patients who have signed the informed consent document. patients belonging to ASA class I-III. Exclusion Criteria: prior surgery to the same hip patients with a history of stroke, neurological or psychiatric disease that potentially could affect the perception of pain obesity (BMI > 35) active or suspected infection patients taking opioids or steroids patients suffering from rheumatoid arthritis or an immunological depression patients who are allergic to any of the drugs being used in this study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Harsten, M.D.
Organizational Affiliation
Region Skane
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept Orthopedic Surgey, Hässleholm Hospital, PO Box 351,
City
Hässleholm
ZIP/Postal Code
28125
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18211990
Citation
Fowler SJ, Symons J, Sabato S, Myles PS. Epidural analgesia compared with peripheral nerve blockade after major knee surgery: a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2008 Feb;100(2):154-64. doi: 10.1093/bja/aem373.
Results Reference
background
PubMed Identifier
2361330
Citation
Marsh BJ, Morton NS, White M, Kenny GN. A computer controlled infusion of propofol for induction and maintenance of anaesthesia in children. Can J Anaesth. 1990 May;37(4 Pt 2):S97. No abstract available.
Results Reference
background
PubMed Identifier
9009936
Citation
Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997 Jan;86(1):24-33. doi: 10.1097/00000542-199701000-00005.
Results Reference
background
PubMed Identifier
25736216
Citation
Harsten A, Kehlet H, Ljung P, Toksvig-Larsen S. Total intravenous general anaesthesia vs. spinal anaesthesia for total hip arthroplasty. Acta Anaesthesiol Scand. 2015 Apr;59(4):542-3. doi: 10.1111/aas.12495. Epub 2015 Mar 3. No abstract available.
Results Reference
background

Learn more about this trial

General or Regional Anesthesia for Hip Surgery

We'll reach out to this number within 24 hrs